Loading...
Please wait, while we are loading the content...
Similar Documents
Ultrasound guided high intensity focused ultrasound (USgHIFU) for malignant tumors: survival advantage in stage III and IV pancreatic cancer.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Vidal-Jove, Joan Perich, Eloi Jaen, Àngels Manuel, Alvarez Del Castillo |
| Copyright Year | 2015 |
| Abstract | Methods From February 2008 to April 2014 we have treated 148 malignant cases. Of those, 48 cases of non resectable pancreatic tumors were treated from March 2010 to April 2014, and we include the first 43 patients to the analysis (until December 2013). All of them underwent systemic chemotherapy with a standard combination. Clinical responses (thermical ablation achieved) were measured by image techniques. They were 29 Stage III cases and 14 Stage IV cases. Complications were also analyzed. |
| Starting Page | O79 |
| Ending Page | O79 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://jtultrasound.biomedcentral.com/track/pdf/10.1186/2050-5736-3-S1-O79 |
| PubMed reference number | 4489514 |
| Volume Number | 3 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Ablation Malignant Neoplasms Pancreatic Neoplasm Pancreatic carcinoma Patients Stage level 3 Systemic Chemotherapy Ultrasonography stage IV childhood Hodgkin's lymphoma |
| Content Type | Text |
| Resource Type | Article |
